昊海生科拟受让瑞济生物19.8%股权，切入生物羊膜赛道

Core Viewpoint - Haohai Biological Technology (688366) plans to acquire 8.4661 million shares of Jiangxi Ruiji Biological Engineering Technology Co., Ltd. for 38.3515 million yuan, representing 19.8% of Ruiji's total share capital [1] Group 1: Company Acquisition - The acquisition will be funded by the company's own capital [1] - The target company, Ruiji Biological, was established in 2002 and specializes in the production and sales of biological amniotic membranes [1] - The main products include convex and concave amniotic membrane products, biological orthopedic amniotic membrane products, and wet biological amniotic membrane products, classified as Class III medical devices [1] Group 2: Market and Product Applications - The products are primarily used in orthopedic and ophthalmic fields, including tendon repair, treatment of ocular burns and injuries, and support after lacrimal duct obstruction procedures [1] - By investing in Ruiji Biological, the company aims to gain distribution rights for Ruiji's products in China, effectively entering the high-value medical device market of biological amniotic membranes [1] - This acquisition will enhance the company's existing product portfolio and expand its business coverage in the ophthalmic and orthopedic sectors [1]